Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Australian vets treat anteater for ant allergy
Ants are an echidna’s main source of food.
Echidna in recovery after receiving allergen-specific vaccine

Vets and keepers at a zoo in Australia are celebrating after successfully treating an echidna who was found to be allergic to ants.

Ants are an echidna’s main source of food, so staff at Healesville Sanctuary, Victoria, were surprised when one of their spiny residents had an unusual reaction to them.

The echidna, named Matilda, was first presented to the sanctuary in 2010 after she was accidentally dug up from her burrow. Thought to be around three months old, she would have just started eating termites and ants.

Keepers became surrogates to Matilda as she had not been weaned, and she soon settled into her new environment. But at two years old, the skin around her eyes started to look a little inflamed.

The keepers provided topical treatments and cleaned the eyes but, after a noticeable spread of the inflammation, Matilda was transferred to the Melbourne Veterinary Specialist Centre for allergy testing.

To determine the cause of the inflammation, specialists injected a range of know antigens under Matilda’s skin and observed her for reactions. Once ants were identified as the cause, specialists got to work on developing an allergen-specific vaccine that was unique to her. She then underwent a period of ‘desensitisation’.

‘Matilda’s treatment plan required her vaccine to be given in small, regular doses, exposing her to enough of the allergen to cause an immune response but not so much that it would cause an adverse reaction,’ a spokesperson for Healesville Sanctuary explains. ‘In short, Matilda’s immune system was being trained to learn how to manage and respond to the identified allergens.

‘While time-consuming, this process of desensitisation has been highly effective and become a lifelong solution for Matilda’s allergies.’

Matilda responded well to the treatment and has now been vaccine-free for six months. Thought to be the world’s first allergic echidna, keepers are optimistic that she will now go on to live a long and allergy-free life.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.